6Langley RW,Burch HB.Perioperative management of the thyrotoxic patient[J]. Endocrinol Metab Clin North Am,2003,32(2):519-534.
7Friend DG.Iodide therapy and the importance of quantitating the dose[J].N Engl J Med,1960,263:1358-1360.
8Braga M,Cooper DS.Clinical nreview 129:Oral cholecystographic agents and the thyroid[J].J Clin Endocrinol Metab,2001,86(5):1853-1860.
9Alsanea O,Clark OH.Treatment of Graves' disease:the advantage of surgery[J].Endocrinol Metab Clin North Am,2000,29(2):321-337.
10Muller PE,Bein B,Robens E,et al.Thyroid surgery according to Enderlen-Hotz or Dunhill:a comparison of two surgical methods for the treatment of Graves' disease[J].Int Surg,2001,86(2):112-116.
8Bukvie B,Zivaljevic V, Sipetic S, et al. Improved quality of life in hyperthyroidism patients after surgery[J]. J Surg Res, 2015,193 (2) : 724-730.
9Sasaki A , Nitta H, Otsuka K, et al. Endoscopic subtotal thyroid ectomy :the procedure of choice for graves'disease? [J]. World J Surg,2009,33(1) :67-71.
10Woeber KA. Update on the management of hyperthyroidism and hypothyroidism[J]. Arch Intern Med, 2000, 160 (8) : 1067-1071.
